A protein interaction landscape of breast cancer.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
Oct 2021
Historique:
entrez: 30 9 2021
pubmed: 1 10 2021
medline: 21 10 2021
Statut: ppublish

Résumé

Cancers have been associated with a diverse array of genomic alterations. To help mechanistically understand such alterations in breast-invasive carcinoma, we applied affinity purification–mass spectrometry to delineate comprehensive biophysical interaction networks for 40 frequently altered breast cancer (BC) proteins, with and without relevant mutations, across three human breast cell lines. These networks identify cancer-specific protein-protein interactions (PPIs), interconnected and enriched for common and rare cancer mutations, that are substantially rewired by the introduction of key BC mutations. Our analysis identified BPIFA1 and SCGB2A1 as PIK3CA-interacting proteins, which repress PI3K-AKT signaling, and uncovered USP28 and UBE2N as functionally relevant interactors of BRCA1. We also show that the protein phosphatase 1 regulatory subunit spinophilin interacts with and regulates dephosphorylation of BRCA1 to promote DNA double-strand break repair. Thus, PPI landscapes provide a powerful framework for mechanistically interpreting disease genomic data and can identify valuable therapeutic targets.

Identifiants

pubmed: 34591612
doi: 10.1126/science.abf3066
pmc: PMC9040556
mid: NIHMS1796644
doi:

Substances chimiques

Neoplasm Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabf3066

Subventions

Organisme : NCI NIH HHS
ID : R50 CA243885
Pays : United States
Organisme : NIGMS NIH HHS
ID : P41 GM103504
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA138804
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA262227
Pays : United States
Organisme : NCI NIH HHS
ID : F32 CA239333
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA209891
Pays : United States
Organisme : NCI NIH HHS
ID : F32 CA239336
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA184427
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18107-12
pubmed: 17108083
Nature. 2007 Jul 26;448(7152):439-44
pubmed: 17611497
Nature. 2012 May 16;486(7403):400-4
pubmed: 22722201
Nat Commun. 2020 Feb 5;11(1):735
pubmed: 32024846
J Clin Invest. 2016 Aug 1;126(8):2903-18
pubmed: 27454287
Nat Commun. 2019 Aug 8;10(1):3574
pubmed: 31395879
Anal Biochem. 2005 Mar 1;338(1):136-42
pubmed: 15707944
Cell. 2018 Dec 13;175(7):1931-1945.e18
pubmed: 30550790
Curr Opin Genet Dev. 2019 Feb;54:110-117
pubmed: 31288129
Science. 2003 Oct 24;302(5645):639-42
pubmed: 14576433
Nat Methods. 2013 Nov;10(11):1108-15
pubmed: 24037242
Cancer Res. 2016 May 1;76(9):2778-90
pubmed: 27197267
Cancer Cell. 2014 Feb 10;25(2):243-56
pubmed: 24525237
Cell Cycle. 2012 Apr 15;11(8):1573-82
pubmed: 22456334
Nat Struct Mol Biol. 2007 Oct;14(10):941-8
pubmed: 17873885
Cell. 2021 May 27;184(11):3022-3040.e28
pubmed: 33961781
Cell. 2015 Oct 22;163(3):712-23
pubmed: 26496610
Methods Mol Biol. 2012;920:379-91
pubmed: 22941618
Biochimie. 2006 Sep;88(9):1099-113
pubmed: 16737766
Clin Pharmacol Ther. 2009 Jul;86(1):97-100
pubmed: 19440188
Nat Genet. 2015 Feb;47(2):106-14
pubmed: 25501392
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Mol Cell. 2006 May 5;22(3):383-94
pubmed: 16678110
NPJ Breast Cancer. 2017 Aug 25;3:31
pubmed: 28948212
Nat Biotechnol. 2014 Mar;32(3):223-6
pubmed: 24727771
BMC Cell Biol. 2010 Oct 12;11:77
pubmed: 20939895
J Biol Chem. 1994 Oct 7;269(40):25067-72
pubmed: 7929193
Cell. 2006 Aug 11;126(3):529-42
pubmed: 16901786
Science. 2009 Dec 18;326(5960):1707-11
pubmed: 19892943
Mol Cell. 2016 Feb 4;61(3):434-448
pubmed: 26778126
Am J Respir Cell Mol Biol. 2015 May;52(5):525-34
pubmed: 25265466
Breast Cancer Res Treat. 1999 Nov;58(2):137-40
pubmed: 10674878
Hum Mutat. 2001 Jun;17(6):520-1
pubmed: 11385711
Bioinformatics. 2014 Sep 1;30(17):2524-6
pubmed: 24794931
EMBO J. 2004 Feb 25;23(4):833-43
pubmed: 14976552
Nat Commun. 2019 Jan 2;10(1):10
pubmed: 30602777
Nat Rev Cancer. 2002 Jul;2(7):489-501
pubmed: 12094235
Br J Cancer. 2006 Mar 13;94(5):661-71
pubmed: 16495925
Hum Mol Genet. 2005 May 15;14(10):1283-92
pubmed: 15800014
N Engl J Med. 2016 Jul 7;375(1):23-34
pubmed: 27406347
Cell Physiol Biochem. 2018;47(6):2350-2359
pubmed: 29990989
Nature. 2018 Jul;559(7713):285-289
pubmed: 29973717
Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1090-6
pubmed: 18021217
Cold Spring Harb Perspect Biol. 2015 Apr 01;7(4):a016600
pubmed: 25833843
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4240-5
pubmed: 10200246
Cell. 2009 Jul 23;138(2):389-403
pubmed: 19615732
BMC Biol. 2013 Apr 15;11:36
pubmed: 23587167
Mol Cell Biol. 2006 Jan;26(1):63-76
pubmed: 16354680
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Nat Cell Biol. 2019 Jun;21(6):778-790
pubmed: 31160710
Nature. 2010 Jul 1;466(7302):68-76
pubmed: 20562859
J Proteomics. 2014 Apr 04;100:37-43
pubmed: 24513533
Nat Commun. 2019 Nov 28;10(1):5438
pubmed: 31780666
Nat Methods. 2015 Jul;12(7):615-621
pubmed: 26125594
Cell. 2015 Jul 16;162(2):425-440
pubmed: 26186194
Science. 2017 May 26;356(6340):
pubmed: 28495876
Nat Commun. 2020 Jan 24;11(1):499
pubmed: 31980649
Am J Hum Genet. 1997 May;60(5):1059-67
pubmed: 9150153
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
PLoS One. 2013;8(3):e56929
pubmed: 23472073
J Clin Invest. 2016 Aug 1;126(8):3145-57
pubmed: 27454289
J Cell Sci. 2013 Jan 15;126(Pt 2):393-401
pubmed: 23525005
Breast Cancer Res Treat. 2011 Aug;128(3):811-5
pubmed: 21318603
Biochem Soc Trans. 2011 Aug;39(4):1023-7
pubmed: 21787341
Cell. 2018 Apr 5;173(2):499-514.e23
pubmed: 29576454
Cell. 2008 Jul 25;134(2):256-67
pubmed: 18662541
Cell. 2017 Aug 10;170(4):605-635
pubmed: 28802037
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Science. 1997 Jul 25;277(5325):567-70
pubmed: 9228007
J Clin Invest. 2014 Feb;124(2):859-70
pubmed: 24463450
JCO Precis Oncol. 2018 Aug 16;2:
pubmed: 32914002
PLoS One. 2009 Jul 21;4(7):e6298
pubmed: 19621083
Sci Signal. 2010 Dec 07;3(151):rs3
pubmed: 21139141
Mol Cell. 2015 Mar 19;57(6):1022-1033
pubmed: 25728766
Nat Protoc. 2019 Jan;14(1):1-27
pubmed: 30559373
Nat Cell Biol. 2011 Oct 03;13(10):1161-9
pubmed: 21968989
Am J Hum Genet. 2000 Jun;66(6):1963-8
pubmed: 10788334
Genomics. 2002 Sep;80(3):254-8
pubmed: 12213194
Cell Rep. 2018 Apr 03;23(1):239-254.e6
pubmed: 29617664
Sci Signal. 2012 Sep 18;5(242):rs6
pubmed: 22990118
Nat Commun. 2018 Aug 29;9(1):3510
pubmed: 30158528
Nat Genet. 1996 Dec;14(4):430-40
pubmed: 8944023
Science. 1994 Oct 7;266(5182):120-2
pubmed: 7939630
Mol Biol Rep. 2015 May;42(5):977-88
pubmed: 25407308
Cancer Res. 2016 Apr 1;76(7):1733-45
pubmed: 26921330
Nat Commun. 2018 Jul 4;9(1):2601
pubmed: 29973584
Nat Cell Biol. 2013 May;15(5):472-80
pubmed: 23604317
Nat Commun. 2020 Feb 5;11(1):729
pubmed: 32024854
J Med Genet. 2015 Aug;52(8):553-6
pubmed: 26101330
Oncogene. 2009 Aug 27;28(34):3022-32
pubmed: 19543317
Genes Dev. 2014 Sep 1;28(17):1957-75
pubmed: 25184681
Curr Biol. 1997 Apr 1;7(4):261-9
pubmed: 9094314
Nat Biotechnol. 2009 Feb;27(2):199-204
pubmed: 19182785
PLoS Biol. 2009 Jun 9;7(6):e1000126
pubmed: 19513107
Nat Commun. 2020 May 19;11(1):2485
pubmed: 32427931
Mol Cell. 2015 May 21;58(4):690-8
pubmed: 26000852
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Mol Cell. 2007 Mar 9;25(5):663-75
pubmed: 17349954
Oncol Lett. 2020 Oct;20(4):24
pubmed: 32774497
Cancer Discov. 2018 Nov;8(11):1474-1489
pubmed: 30209081
J Clin Oncol. 2011 Dec 10;29(35):4688-95
pubmed: 22025163
Mol Cell Biol. 2014 Jun;34(11):2062-74
pubmed: 24687851
Science. 2011 Oct 28;334(6055):525-8
pubmed: 22034435
Cancer Res. 2009 Apr 15;69(8):3625-33
pubmed: 19336573
Oncogene. 2006 Sep 25;25(43):5854-63
pubmed: 16998500
Genome Biol. 2016 Jun 23;17(1):129
pubmed: 27333808
Nat Struct Mol Biol. 2010 Apr;17(4):459-64
pubmed: 20305656
Mol Endocrinol. 1997 Dec;11(13):1911-23
pubmed: 9415396
Nucleic Acids Res. 2021 Jan 8;49(D1):D394-D403
pubmed: 33290554
Cell. 2018 Dec 13;175(7):1917-1930.e13
pubmed: 30550789
Exp Cell Res. 2007 May 15;313(9):1735-44
pubmed: 17428466
Science. 1994 Oct 7;266(5182):66-71
pubmed: 7545954
Cancer Discov. 2019 Nov;9(11):1606-1627
pubmed: 31350328
Nucleic Acids Res. 2017 Jan 4;45(D1):D362-D368
pubmed: 27924014
Oncotarget. 2015 Sep 29;6(29):27674-87
pubmed: 26320175
Curr Opin Cell Biol. 2013 Feb;25(1):39-46
pubmed: 23127608
Elife. 2017 Apr 11;6:
pubmed: 28398198
Cell. 2018 Apr 5;173(2):321-337.e10
pubmed: 29625050
Nature. 2017 May 25;545(7655):505-509
pubmed: 28514442
Nat Struct Mol Biol. 2004 Jun;11(6):512-8
pubmed: 15133502
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
Cell. 1998 Feb 6;92(3):291-4
pubmed: 9476889
Science. 2007 Nov 16;318(5853):1108-13
pubmed: 17932254
J Biol Chem. 1998 Mar 6;273(10):5858-68
pubmed: 9488723
Science. 1999 Nov 5;286(5442):1162-6
pubmed: 10550055
J Clin Oncol. 2020 Apr 1;38(10):1059-1069
pubmed: 32031889
Mol Cell Biol. 2004 Nov;24(21):9478-86
pubmed: 15485915
Prog Biophys Mol Biol. 2015 Mar;117(2-3):143-148
pubmed: 25701377
Cell. 2016 Jul 28;166(3):740-754
pubmed: 27397505
J Med Genet. 2005 Feb;42(2):172-6
pubmed: 15689457
Cancer Res. 2002 Aug 15;62(16):4588-91
pubmed: 12183412

Auteurs

Minkyu Kim (M)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.
The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.
The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.

Jisoo Park (J)

The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Department of Medicine, University of California, San Diego, CA, USA.

Mehdi Bouhaddou (M)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.
The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.
The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.

Kyumin Kim (K)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.
The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.
The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.

Ajda Rojc (A)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.
The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.
The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.

Maya Modak (M)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.
The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.
The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.

Margaret Soucheray (M)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.
The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.
The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.

Michael J McGregor (MJ)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.
The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.
The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.

Patrick O'Leary (P)

The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.

Denise Wolf (D)

The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.

Erica Stevenson (E)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.
The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.
The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.

Tzeh Keong Foo (TK)

Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.

Dominique Mitchell (D)

Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.
Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
Division of Hematology/Oncology, University of California, San Francisco, CA, USA.

Kari A Herrington (KA)

Department of Biochemistry and Biophysics, Center for Advanced Light Microscopy, University of California, San Francisco, CA, USA.

Denise P Muñoz (DP)

The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.

Beril Tutuncuoglu (B)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.
The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.
The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.

Kuei-Ho Chen (KH)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.
The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.
The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.

Fan Zheng (F)

The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Department of Medicine, University of California, San Diego, CA, USA.

Jason F Kreisberg (JF)

The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Department of Medicine, University of California, San Diego, CA, USA.

Morgan E Diolaiti (ME)

The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.

John D Gordan (JD)

Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.
Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
Division of Hematology/Oncology, University of California, San Francisco, CA, USA.

Jean-Philippe Coppé (JP)

The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.

Danielle L Swaney (DL)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.
The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.
The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.

Bing Xia (B)

Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.

Laura van 't Veer (L)

The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.

Alan Ashworth (A)

The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.

Trey Ideker (T)

The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Department of Medicine, University of California, San Diego, CA, USA.
Department of Bioengineering, University of California, San Diego, CA, USA.

Nevan J Krogan (NJ)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.
The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.
The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH